Copyright © 2016
Aridis Pharmaceuticals, Inc.
5941 Optical Court, San Jose, CA 95138
Scientific Advisory Board
Roger Pomerantz, M.D.
Dr. Pomerantz is currently President, Chief Executive Officer, and Chairman of the Board of Directors of Seres Therapeutics, Inc. ("Seres"). He was formerly Worldwide Head of Licensing & Acquisitions, Senior Vice President at Merck & Co., Inc. where he oversaw all licensing and acquisitions at Merck Research Laboratories. Previously, he served as Senior Vice President and Global Franchise Head of Infectious Diseases at Merck. Prior to joining Merck, Roger was Global Head of Infectious Diseases for Johnson & Johnson Pharmaceuticals, responsible for all anti-
Harry Greenberg, M.D.
Dr. Greenberg is currently the Joseph D. Grant Professor of Medicine and Microbiology and Immunology and the Senior Associate Dean for Research and Training at Stanford University School of Medicine. He was formerly Sr. Vice President and Chief Scientific Officer at Aviron. He is a virologist and a world leader in enteric diseases, as well as one of the inventors of bovine rotavirus vaccine™. An expert in vaccine safety and efficacy, he serves as a member of the CDC’s Advisory Committee on Immunization Practices (ACIP) and as chairman of the FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC). He has published more than 350 scientific papers, served on the editorial boards of a number of journals and is currently an editor of the Journal of Virology. Dr. Greenberg is a member or fellow of a variety of scholarly societies, including the ASCI, AAP, ASV and the AAAS. Dr. Greenberg received his M.D. from Columbia College of Physicians and Surgeons in 1970.
Steven Opal, M.D.
Dr. Opal served as chief of the infectious disease division at Memorial Hospital of Rhode Island and has served as the principal investigator for numerous, worldwide, multi-
John S. Patton, Ph.D.
Dr. Patton was Co-
Jerry Pier, Ph.D.
Dr. Pier is Professor of Medicine, Microbiology and Molecular Genetics at Brigham and Women’s Hospital, Harvard Medical School. He is a molecular microbiologist and a recognized expert on Pseudomonas and Staphylococci and is the inventor of human anti-
Arnold Smith, M.D.
Dr. Smith is Professor of Pediatrics in the Department of Pathobiology, University of Washington and a Member of the Seattle Biomedical Research Institute. He spent more than 15 years developing better antibiotic treatment for children with cystic fibrosis at Children's Hospital and Regional Medical Center in Seattle. Dr. Smith performed the first clinical trials demonstrating efficacy of inhaled tobramycin against CF lung infections. A pediatric infectious disease expert, Dr. Smith spent the first two decades of his academic career at Harvard Medical School and then at University of Missouri School of Medicine as part of teams that developed a vaccine to prevent life-
Breakthrough Therapies for
Antibiotic Resistant Infections